Claripi

About Claripi

Claripi is a South Korean company founded in February 2015 by CEO Jong Hyo Kim and President Hyun Sook Park. The firm specializes in developing artificial intelligence-based solutions for the medical imaging sector, an idea born from long-term collaborative research between engineering and medical experts. Jong Hyo Kim also holds a professorship at the Graduate School of Convergence Science and Technology and College of Medicine at Seoul National University. The company's business model is B2B, providing its software to medical imaging experts to enhance diagnostic confidence and workflow efficiency with clearer imaging from low-dose radiation scans.

Claripi's product suite aims to address the risks associated with radiation from CT scans by allowing for the use of ultra-low doses without compromising image quality. The flagship product, ClariCT.AI, is a vendor-neutral, deep-learning CT denoising solution that has received FDA clearance and CE marking. It processes DICOM standard images to remove noise and artifacts, enhancing anatomical structures to make low-dose CT image quality comparable to that of high-dose scans. Other key products include ClariPulmo, an AI-powered 3D reporting tool for lung conditions like emphysema; ClariSIGMAM, which analyzes breast density from mammograms; ClariAdipo for measuring abdominal fat; ClariOsteo for assessing spine fracture and osteoporosis risks; and ClariACE, which enhances contrast in CT images. Claripi's software is available through platforms like the Nuance AI Marketplace and Siemens Healthineers Digital Marketplace, integrating with existing hospital PACS and IT infrastructure.